Key points from article :
A groundbreaking genetic surveillance system has been launched in the UK to prevent future pandemics. Run by the UK Health Security Agency (UKHSA), this program will scan NHS samples for unknown pathogens, using an advanced technique called metagenomics. Unlike traditional genomic methods that require prior knowledge of the pathogen, metagenomics can identify new and emerging diseases without needing a specific target. This program will allow for faster detection of outbreaks and a better understanding of their origins and potential risks.
The new system aims to prevent future pandemics by enabling quicker responses and predicting the effectiveness of treatments. It could have been particularly beneficial during the early stages of the Covid-19 pandemic, potentially spotting the virus much sooner. According to Professor Susan Hopkins, UKHSA’s Chief Medical Adviser, this program harnesses the UK's expertise in genomics to help identify and track new pathogens in real-time.
Professor Dame Sue Hill, Chief Scientific Officer for NHS England, also emphasized that genomics is transforming medical practices, from diagnosing rare diseases to personalizing cancer treatments. The mSCAPE program exemplifies the UK’s global leadership in genomics, positioning the country to act swiftly in response to future health threats.
